In the last trading session, 0.17 million shares of the FibroBiologics Inc (NASDAQ:FBLG) were traded, and its beta was -1.02. Most recently the company’s share price was $1.75, and it changed around -$0.16 or -8.38% from the last close, which brings the market valuation of the company to $61.61M. FBLG currently trades at a discount to its 52-week high of $55.00, offering almost -3042.86% off that amount. The share price’s 52-week low was $1.08, which indicates that the current value has risen by an impressive 38.29% since then. We note from FibroBiologics Inc’s average daily trading volume that its 10-day average is 0.14 million shares, with the 3-month average coming to 156.68K.
FibroBiologics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended FBLG as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. FibroBiologics Inc is expected to report earnings per share of -0.07 for the current quarter.
FibroBiologics Inc (NASDAQ:FBLG) trade information
Instantly FBLG has showed a red trend with a performance of -8.38% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.1291 on recent trading dayincreased the stock’s daily price by 17.81%. The company’s shares are currently down -12.50% year-to-date, but still down -6.91% over the last five days. On the other hand, FibroBiologics Inc (NASDAQ:FBLG) is -18.98% down in the 30-day period. We can see from the shorts that 2.47 million shares have been sold at a short interest cover period of 18.7 day(s).
The consensus price target as assigned by Wall Street analysts is $9, which translates to bulls needing to increase their stock price by 80.56% from its current value. Analyst projections state that FBLG is forecast to be at a low of $9 and a high of $9.
FibroBiologics Inc (FBLG) estimates and forecasts
FibroBiologics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -64.93 percent over the past six months and at a 50.00% annual growth rate that is well above the industry average of 16.50%.
FBLG Dividends
FibroBiologics Inc’s next quarterly earnings report is expected to be released in February.
iShares Russell 2000 ETF and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Oct 31, 2024 . The former held 627.68 shares worth $1.1 million, making up 1.78% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 407.67 shares worth around $0.71 million, which represents about 1.16% of the total shares outstanding.
